Clonal mast cell activation syndrome with anaphylaxis to sulfites

International Archives of Allergy and Immunology

Volumn 162, Issue 1, 2013, Pages 94-96

  Cifuentes, Liliana ^a   Ring, Johannes ^a   Brockow, Knut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anaphylaxis; Mast cell activation syndrome; Sulfites; Systemic mastocytosis

Indexed keywords

ALENDRONIC ACID; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIMETINDENE; FEXOFENADINE; INORGANIC SALT; POTASSIUM METABISULFITE; RANITIDINE; TRYPTASE; UNCLASSIFIED DRUG; ACETYLSALICYLIC ACID; ADRENALIN; ALCOHOL; CODEINE; FOOD ADDITIVE; HISTAMINE; PARACETAMOL; SULFITE;

ADULT; ANAPHYLAXIS; ARTICLE; BONE MARROW BIOPSY; CANNED FOOD; CASE REPORT; CHEESE; CLONAL MAST CELL ACTIVATION SYNDROME; DIZZINESS; EXAMINATION; FAINTNESS; FLUSHING; FOOD INTAKE; GRASS POLLEN; HAY FEVER; HEART PALPITATION; HUMAN; HYPOTENSION; IMMUNOPHENOTYPING; MALE; MASTOCYTOSIS; OLIVE; ONION; ORANGE JUICE; PASTA; PRESCRIPTION; PRIORITY JOURNAL; PROVOCATION TEST; RED WINE; SENSITIZATION; SKIN BIOPSY; SKIN TEST; TACHYCARDIA; TOMATO; TUNA; ALLERGY TEST; BREAD; DISEASE SEVERITY; EPINEPHRINE AUTOINJECTOR; HUMAN TISSUE; IMMEDIATE TYPE HYPERSENSITIVITY; MAST CELL; MAST CELL ACTIVATION SYNDROME; MIDDLE AGED; NAUSEA; OSTEOPOROSIS; POLLEN ALLERGY; UNCONSCIOUSNESS;

ANAPHYLAXIS; CELL PROLIFERATION; CLONE CELLS; FOOD HYPERSENSITIVITY; HUMANS; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; PLACEBOS; SULFITES; SYNDROME;

EID: 84879481898     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000348379     Document Type: Article

References (10)

1. Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: A study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-232.
2. Akin C, Valent P, Metcalfe DD: Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol 2010; 126: 1099- 1104 e4.
3. Valent P, Akin C, Escribano L, et al: Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435-453.
4. Valent P, Akin C, Arock M, et al: Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol 2012; 157: 215-225.
5. Valent P, Horny HP, Triggiani M, Arock M: Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria. Int Arch Allergy Immunol 2011; 156: 119-127.
6. Sonneck K, Florian S, Mullauer L, et al: Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol 2007; 142: 158-164.
7. Akin C, Scott LM, Kocabas CN, et al: Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with 'idiopathic' anaphylaxis. Blood 2007; 110: 2331-2333.
8. Alvarez-Twose I, Gonzalez-de-Olano D, Sanchez-Munoz L, et al: Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms. Int Arch Allergy Immunol 2012; 157: 275- 280.
9. Vally H, Misso NL, Madan V: Clinical effects of sulphite additives. Clin Exp Allergy 2009; 39: 1643-1651.
10. Meggs WJ, Atkins FM, Wright R, Fishman M, Kaliner MA, Metcalfe DD: Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: Results of a single-blind study. J Allergy Clin Immunol 1985; 76: 840-846.